Although a trend toward clinical benefit was observed, the results did not reach statistical significance, possibly because more than 70% of participants also underwent EVT, which may have attenuated the detectable effect of thrombolysis.
← all excerpts
Advances in Reperfusion Therapy and Cytoprotection for Acute Ischemic Stroke.
1
—
—